ENBREL subst sèche 25 mg c solv flac 4 pce

7680553650025 CH-55365 L04AB01 07.15.0.

Reimbursement limitations:

ENBREL4

Traitement par ENBREL exige une garantie préalable de prise en charge des coûts par l’assureur …

ENBREL subst sèche 25 mg c solv flac 4 pce
ENBREL subst sèche 25 mg c solv flac 4 pce
ENBREL subst sèche 25 mg c solv flac 4 pce
1 / 3
google

Details

Product number
5536501
CPT
-
Packaging group
1
Unit
Set
Composition
Praeparatio cryodesiccata: etanerceptum 25 mg, mannitolum, saccharum, trometamolum, trometamoli hydrochloridum, pro vitro. Solvens: aqua ad iniectabile, q.s. ad solutionem pro 1 ml.

Articles (1)

Enbrel 25 mg, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Pulver
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
09/10/2024
Patient information leaflet
Français
09/10/2024
Patient information leaflet
Italien
09/10/2024
Professional SmPC
Allemand
09/10/2024
Professional SmPC
Français
09/10/2024
Professional SmPC
Italien
09/10/2024

Detailed composition

Substance Quantity Type Category
SOLV
- Substance HNIDK
PRC
25.0 MG Substance Wirkstoff (Principe actif)
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK

Reimbursement information

Public price
CHF 455.15
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/04/2000

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
55365
Drug name
Enbrel, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Galenic form
PULP
ATC Code
L04AB01
Authorization status
Z
Dispensation category
B
First authorization
01/02/2000
Authorization expiration date
31/12/9999
IT number
07.15.0.
Domain
Human medicine
Field of application
Rheumatoide Arthritis, aktive juvenile idiopatische Arthritis (Polyarthritis, Oligoarthritis, Psoriasis-Arthritis, Enthesitis-assoziierte Arthritis), Psoriasis-Arthritis, Morbus Bechterew (ankylosierende Spondylitis), mittelschwere bis schwere Plaque-Psoriasis

Packaging details

Description (FR)
ENBREL subst sèche 25 mg c solv flac 4 pce
Description (DE)
ENBREL Trockensub 25 mg c Solv Durchstf 4 Stk
Market launch
01/02/2000
Narcotic (BTM)
No

Other packaging sizes